BMY vs COSO · P/E 17, rev $24.46B vs P/E 12, rev $2.0M
Bristol-Myers Squibb Company (BMY) versus CoastalSouth Bancshares, Inc. (COSO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
CoastalSouth Bancshares, Inc. (COSO) is a banks - regional company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported COSO revenue for 2025-12-31 was $2.0M. Net income was $24.9M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. COSO currently screens at market cap $321.7M and trailing P/E 12.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. COSO currently screens at market cap $321.7M and trailing P/E 12.0.
Not investment advice. Open the BMY and COSO stock pages for the full models.
Not investment advice.